Streetbeat News

Products Services

CLDX

Celldex Therapeutics has initiated a global Phase 3 clinical trial for Barzolvolimab, targeting patients with Chronic Spontaneous Urticaria. This marks a significant milestone in the company's drug development pipeline.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:03 pm

KPLT

Katapult Holdings has announced a strategic partnership with PayTomorrow, integrating Katapult's lease-to-own option into PayTomorrow's financing platform. This move aims to enhance consumer flexibility and choice.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:03 pm

ANVS

Annovis Bio has received FDA approval to transition to a new solid form of Buntanetap, which could potentially enhance the drug's stability and patient compliance.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:02 pm

ANVS

Annovis Bio has received FDA approval to transition to a new crystal form of its drug Buntanetap. This approval is a significant milestone for the company, potentially enhancing the drug's stability and efficacy.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:00 pm

SYRA

Syra Health Corp. (NASDAQ:SYRA) announced it is giving away its AI solution for redacting personally identifiable information in compliance with HIPAA regulations. This move aims to benefit the healthcare and technology community.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:00 pm

TSLA

Tesla CEO Elon Musk voiced against the $7,500 federal EV tax credit, stating that removing subsidies would benefit Tesla. This comes amid Musk's support for Trump and VP pick JD Vance, who proposed eliminating EV subsidies. Despite Musk's stance, Tesla has benefited from subsidies in the past.

Portfolio Pulse from Anan Ashraf

July 16, 2024 | 11:58 am

AAPL

TSM

Apple Inc. (NASDAQ:AAPL) is expected to delay the use of Taiwan Semiconductor's (NYSE:TSM) 2nm chip technology for its iPhone 17 series, opting instead for a refined 3nm chip. This decision is influenced by production delays and Apple's focus on a thinner iPhone design.

Portfolio Pulse from Rounak Jain

July 16, 2024 | 11:57 am

BLK

BlackRock Inc. (NYSE:BLK) CEO Larry Fink highlights a shift in fixed-income markets as investors move from traditional bonds to ETFs and alternative assets. This trend, driven by expectations of a U.S. rate cut and a significant equity rally, has led to record inflows into BlackRock's ETF products and increased interest in infrastructure investments. BlackRock's quarterly revenue rose 8% to $4.81 billion, with net income surpassing expectations at $1.5 billion.

Portfolio Pulse from Benzinga Neuro

July 16, 2024 | 11:54 am

CDT

Conduit Pharmaceuticals shares are trading higher after the company announced it received patent approval for its lead asset targeting autoimmune diseases.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 11:50 am

LASE

Laser Photonics has introduced the new MarkStar Handheld VIN Marking Laser, aimed at preventing theft and counterfeiting.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 11:48 am